Research Article| Volume 25, ISSUE 1, P75-86, January 01, 1989

Alterations in sleep polygraphy after neuroleptic withdrawal: A putative supersensitive dopaminergic mechanism

      This paper is only available as a PDF. To read, Please Download here.


      Although a number of studies have reported sleep disturbances following neuroleptic withdrawal, a full description of such changes in sleep architecture is not available. Polysomnographic, plasma prolactin, and clinical measurements were carried out in a small number of patients on chronic neuroleptic treatment and after drug withdrawal. Preliminary findings show that in these chronically treated schizophrenic patients with and without tardive dyskinesia (TD), abrupt neuroleptic withdrawal induces reductions in total sleep, rapid eye movement (REM) sleep, and plasma prolactin. Furthermore, an increase in delta sleep was observed only in patients without TD. The REM suppression occurred significantly earlier in TD patients compared to the non-TD schizophrenic patients. These changes were transient, and both sleep measures and plasma prolactin stabilized during the 2–4 weeks after withdrawal to levels somewhere between the values observed during chronic treatment and withdrawal (week 1) periods. As the withdrawalinduced exaggerated changes mimicked the dopamine agonist effect on these sleep and hormonal measures, one can hypothesize that the observed changes are due to unmasking of supersensitive dopamine receptors following drug cessation. Normalization of these receptors and/or adaptational changes in other nondopaminergic system(s) can hypothetically explain the eventual stabilization of these measures during the following weeks.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Biological Psychiatry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Adam K
        • Allen S
        • Carruthers-Jones I
        • Oswald I
        • Spence M
        Mesoridazine and human sleep.
        Br J Clin Pharmacol. 1976; 3: 157-163
        • Allen RP
        • Faillace LA
        • Wagman A
        Recovery time for alcoholics after prolonged alcohol intoxication.
        Johns Hopkins Med. 1971; 128: 154-158
        • Brown WA
        • Laughren TP
        Tolerance to the prolactin-elevating effects of neuroleptics.
        Psychiatry Res. 1981; 5: 317-322
        • Brooks GW
        Withdrawal from neuroleptic drugs.
        Am J Psychiatry. 1959; 115: 931-932
        • Cianchetti C
        • Masala C
        • Mangoni A
        • Gessa GL
        Suppression of REM and delta sleep by apomorphine in man: A dopamine mimetic effect.
        Psychopharmacology. 1980; 67: 61-65
        • Chouinard G
        • Jones BD
        Neuroleptic-induced supersensitivity psychosis: Clinical and pharmacologie characteristics.
        Am J Psychiatry. 1980; 137: 16-21
        • Corsini GU
        • Del Zompo M
        • Manconi S
        • Piccardi MD
        • Onali PL
        • Mangoni A
        Evidence for dopamine receptors in the human brain mediating sedation and sleep.
        Life Sci. 1977; 20: 1613-1618
        • DeRivera JL
        • Lal S
        • Ettigi P
        • et al.
        Effect of acute and chronic neuroleptic therapy on serum prolactin levels in men and women of different age groups.
        Clin Endocrinol (Oxford). 1976; 5: 273-282
        • Frohman LA
        • Horton ES
        • Lebovitz HE
        Growth hormone releasing action of a pseudomonas endotoxin (piromen).
        Metabolism. 1967; 16: 57-67
        • Gillin JC
        • Post RM
        • Wyatt RJ
        • Goodwin FK
        • Snyder F
        • Bunney WE
        REM inhibitory effect of L-DOPA infusion during human sleep.
        Electroencephal Clin Neurophysiol. 1973; 35: 181-186
        • Gillin JC
        • VanKammen DP
        • Post RM
        • Sitaram N
        • Wyatt RJ
        • Bunney WE
        What is the role of dopamine in the regulation of sleep-wake activity?.
        in: Apomorphine and Other Dopaminomimetics. vol 2. Raven Press, New York1981: 157-164
        • Greenberg LM
        • Roth S
        Differential effects of abrupt versus gradual withdrawal of chlorpromazine in hospitalized chronic schizophrenic patients.
        Am J Psychiatry. 1966; 123: 221-226
        • Gudelsky GA
        Tuberoinfundibular dopamine neurons and the regulation of prolactin secretion.
        Psychoneuroendocrinology. 1981; 6: 3-16
        • Hartmann E
        • Cravens J
        The effects of long-term administration of psychotropic drugs on human sleep. IV. The effects of chlorpromazine.
        Psychopharmacology. 1973; 33: 203-218
        • Hyttel J
        • Larsen JJ
        • Christensen AV
        • Arnt J
        Receptor-binding profiles of neuroleptics.
        in: Casey E Chase TN Christensen AV Dyskinesia: Research and Treatment. Springer-Verlag, Berlin1985: 9-18
        • Jus K
        • Jus A
        • Beland C
        • Bouchard M
        • Pires P
        • Fontaine P
        • Brunelle R
        Sleep analysis during drug-free weekends in chronic schizophrenic patients.
        Biol Psychiatry. 1976; 11: 709-718
        • Klawans HL
        • Rubovits R
        An experimental model of tardive dyskinesia.
        J Neural Transmiss. 1972; 33: 235-246
        • Kupfer DJ
        • Wyatt RJ
        • Scott J
        • Snyder F
        Sleep disturbance in acute schizophrenic patients.
        Am J Psychiatry. 1970; 126: 1213-1223
        • Lacoursiere RB
        • Spohn HE
        • Thompson K
        Medical effects of abrupt neuroleptic withdrawal.
        Compr Psychiatry. 1976; 17: 285-294
        • Lal S
        • De la Vega CE
        • Sourkes TL
        • Friesen HG
        Effect of apomorphine on growth hormone, prolactin, luteinizing hormone and follicle-stimulating hormone levels in human serum.
        J Clin Endocrinol Metab. 1973; 37: 719-724
        • Langer G
        • Sachaer EJ
        • Halpern FS
        • Gruen PH
        • Solomon M
        The prolactin response to neuroleptic drugs. A test of dopaminergic blockade: Neuroendocrine studies in normal men.
        J Clin Endocrinol Metab. 1977; 45: 996-1002
        • Leblanc H
        • Lachelin GC
        • Abu-Fadil S
        • Yen SS
        Effects of dopamine infusion on pituitary hormone secretion in humans.
        J Clin Endocrinol Metab. 1976; 43: 668-674
        • Lewis SA
        • Evans JI
        Dose effect of chlorpromazine on human sleep.
        Psychopharmacology. 1969; 14: 342-348
        • MacKay AVP
        • Iverson LL
        • Rosser M
        • Spokes E
        • Bird E
        • Arregui A
        • Creese I
        • Snyder SH
        Increased brain dopamine and dopamine receptors in schizophrenia.
        Arch Gen Psychiatry. 1982; 39: 991-997
        • Naber D
        • Fischer H
        • Ackenheil M
        Effect of long-term neuroleptic treatment on dopamine tuberoinfundibular system: Development of tolerance?.
        Commun Psychopharmacol. 1979; 3: 59-65
        • Overall JE
        • Gorham DR
        The Brief Psychiatric Rating Scale.
        Psychol Rep. 1962; 10: 799-812
        • Post RM
        • Gerner RH
        • Carman JS
        • Gillin JC
        • Jimerson DC
        • Goodwin FK
        • Bunney WE
        Effects of the dopamine agonist piribidel in depressed patients.
        Arch Gen Psychiatry. 1978; 34
        • Radulovacki M
        • Wojick WJ
        • Fornal C
        Effects of bromocriptine and alpha-fluphenthixol on sleep in REM sleep deprived rats.
        Life Sci. 1979; 24: 1705-1712
        • Rechtschaffen A
        • Kales A
        A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Neurological Information Network. DREW, Bethesda, MD1968
        • Rupniak MN
        • Jenner P
        • Marsden CD
        The effect of chronic neuroleptic administration on cerebral dopamine receptor function.
        Life Sci. 1985; 32: 2289-2311
        • Schooler NR
        • Kane JM
        Research diagnosis for tardive dyskinesia.
        Am J Psychiatry. 1982; 39: 486-487
        • Shen WW
        • Baig MS
        • Sata LS
        Dopamine receptor supersensitivity and the chemoreceptor trigger zone.
        Biol Psychiatry. 1983; 18: 917-921
        • Smith RC
        • Strizich M
        • Klass D
        History of neuroleptic drugs and tardive dyskinesia.
        in: Fann WE Smith RC Davis JM Domino EF Tardive Dyskinesia: Research and Treatment. SP Medical and Scientific Books, New York1980
        • Spitzer RL
        • Endicott J
        • Robins E
        Research Diagnostic Criteria (RDC) for Selected Group of Functional Disorders.
        Biometrics Research Division, New York State Psychiatric Institute, New York1978
        • Thaker GK
        • Alphs ED
        • Tamminga CA
        Labile hypertension after abrupt neuroleptic withdrawal: A case report.
        Biol Psychiatry. 1985; 20: 1244-1246
        • Thaker GK
        • Tamminga CA
        • Wagman AM
        Sleep EEG in schizophrenic patients with and without tardive dyskinesia.
        in: Presented at International Congress on Schizophrenia Research., Clearwater, FL1987
        • Vardi J
        • Glaubman H
        • Rabey J
        • Streifler M
        EEG sleep patterns in parkinsonian patients treated with bromocriptine and L-DOPA: A comparative study.
        J Neural Transmiss. 1979; 45: 307-316
        • Watson R
        • Hartmann E
        • Schildkraut JJ
        Amphetamine withdrawal: Affective state, sleep patterns, and MHPG excretion.
        Am J Psychiatry. 1972; 129: 263-269
        • Wauquier A
        • Van den Broeck WAE
        • Janssen PA
        Biphasic effects of pimozide on sleepwakefulness in dogs.
        Life Sci. 1980; 27: 1469-1475
        • Wyatt RJ
        • Chase TN
        • Kupfer DJ
        • Scott J
        • Snyder F
        • Sjoerdsma A
        • Engelman K
        Brain catecholamines and human sleep.
        Nature. 1971; 233: 63-65
        • Zarcone VP
        • Benson KL
        • Berger PA
        Abnormal rapid eye movement latencies in schizophrenia.
        Arch Gen Psychiatry. 1987; 44: 45-48